| HCV-RNA (b-DNA) | sustained responder to therapy | sustained non-responder | ||
No. | total | No. | total | ||
At week 4 | <615 IU/ml | 21/24 (87.5%) | 41/57 (72%) | 3/24 (12.5%) | 16/57 (28.1%) |
>615 IU/ml | 20/33 (60.6%) | 13/33 (39.4%) | |||
At week 12 | <615 IU/ml | 35/45 (77.7%) | 45/57 (78.9%) | 10/45 (22.2%) | 16/57 (28.1%) |
>615 IU/ml | 6/12 (50%) | 6/12 (50%) |